ScholarIQanswers from OpenAlex & ORCID
Thomas R. Pieber
ResearcherPublications, citations & collaboration network
Thomas R. Pieber is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Thomas R. Pieber have?
ScholarIQindexed works
Thomas R. Pieber has 841 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Thomas R. Pieber have?
ScholarIQcitation count
Thomas R. Pieber has 34,045 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Thomas R. Pieber?
ScholarIQh-index
Thomas R. Pieber has an h-index of 95 in OpenAlex.
What is the i10-index of Thomas R. Pieber?
ScholarIQi10-index
Thomas R. Pieber has an i10-index of 390 in OpenAlex.
What is the ORCID of Thomas R. Pieber?
ScholarIQorcid
The ORCID for Thomas R. Pieber is on the source record.
What is the OpenAlex record for Thomas R. Pieber?
ScholarIQopenalex
The OpenAlex for Thomas R. Pieber is on the source record.
What are the most-cited papers on Thomas R. Pieber?
ScholarIQmost cited works
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
Steven P. Marso, Darren K. McGuire, Bernard Zinman, Neil R Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, Poul-Martin Haahr, Martin Lange, Kirstine Brown‐Frandsen, Alan C. Moses, Simon Skibsted, Kajsa Kvist, John B. Buse
Effect of High-Dose Vitamin D <sub>3</sub> on Hospital Length of Stay in Critically Ill Patients With Vitamin D Deficiency
Karin Amrein, Christian Schnedl, Alexander Höll, Regina Riedl, Kenneth B. Christopher, Christoph Pachler, Tadeja Urbanic Purkart, Andreas Waltensdorfer, Andreas Münch, H Warnkroß, Tatjana Stojaković, Egbert Bisping, Wolfgang Toller, Karl‐Heinz Smolle, Andrea Berghold, Thomas R. Pieber, Harald Dobnig
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis
Klaus Jeitler, Karl Horvath, Andrea Berghold, Thomas W Gratzer, Kurt Neeser, Thomas R. Pieber, Andrea Siebenhofer
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
Karl Horvath, Klaus Jeitler, Andrea Berghold, Susanne H Ebrahim, Thomas W Gratzer, Johannes Plank, Thomas Kaiser, Thomas R. Pieber, Andrea Siebenhofer
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
David C. Klonoff, Jing Wang, David Rodbard, Michael A. Kohn, Chengdong Li, Dorian Liepmann, David Kerr, David Ahn, Anne L. Peters, Guillermo E. Umpierrez, Jane Jeffrie Seley, Nicole Y. Xu, Kevin T. Nguyen, Gregg D. Simonson, Michael S. D. Agus, Mohammed E. Al‐Sofiani, Gustavo Armaiz-Peña, Timothy S. Bailey, Ananda Basu, Tadej Battelino, Sewagegn Yeshiwas, Pierre‐Yves Benhamou, B. Wayne Bequette, Thomas Blevins, Marc D. Breton, Jessica R. Castle, J. Geoffrey Chase, Kong Y. Chen, Pratik Choudhary, Mark A. Clements, Kelly L. Close, Curtiss B. Cook, Thomas Danne, Francis J. Doyle, Angela Drincic, Kathleen Dungan, Steven V. Edelman, Niels Ejskjær, Juan Espinoza, G. Alexander Fleming, Gregory P. Forlenza, Guido Freckmann, Rodolfo J. Galindo, Ana María Gómez, Hanna A. Gutow, Lutz Heinemann, Irl B. Hirsch, Thanh D. Hoang, Roman Hovorka, Johan Jendle, Linong Ji, Shashank Joshi, Michaël Joubert, Suneil K. Koliwad, Rayhan Lal, M. Cecilia Lansang, Wei-An Lee, Lalantha Leelarathna, Lawrence A. Leiter, Marcus Lind, Michelle L. Litchman, Julia K. Mader, Katherine Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Mathioudakis, Alexander Yur'evich Mayorov, Jordan Messler, Joshua D. Miller, Viswanathan Mohan, James H. Nichols, Kirsten Nørgaard, David N. O’Neal, Francisco J. Pasquel, Athena Philis‐Tsimikas, Thomas R. Pieber, Moshe Phillip, William H. Polonsky, Rodica Pop‐Busui, Gerry Rayman, Eun‐Jung Rhee, Steven J. Russell, Viral N. Shah, Jennifer L. Sherr, Koji Sode, Elias K. Spanakis, Deborah J. Wake, Kayo Waki, Amisha Wallia, Melissa E. Weinberg, Howard Wolpert, Eugene E. Wright, Mihail Zilbermint, Boris Kovatchev